NCT01415401View on ClinicalTrials.gov

Efficacy and Tolerability of AZARGA® as Replacement Therapy in Patients on COMBIGAN® Therapy in Canada

PHASE4CompletedINTERVENTIONAL
Enrollment

57

Participants

Timeline

Start Date

September 30, 2011

Primary Completion Date

June 30, 2013

Study Completion Date

June 30, 2013

Conditions
GlaucomaOcular HypertensionOpen-angle Glaucoma
Interventions
DRUG

Brinzolamide 1% / timolol 0.5% maleate fixed combination

Sponsors

Lead Sponsor

Alcon Research
All Listed Sponsors
lead

Alcon Research

INDUSTRY

NCT01415401 - Efficacy and Tolerability of AZARGA® as Replacement Therapy in Patients on COMBIGAN® Therapy in Canada | Biotech Hunter | Biotech Hunter